Oncolytics Biotech Inc. (ONCY)
undefined
undefined%
At close: undefined
0.82
0.79%
After-hours Dec 13, 2024, 06:31 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Revenue - - - - - - - - - - - 4.85M - - - - - - 783.46K 699.76K 313.31K 208.87K - 310.00K 1.00
Cost of Revenue 403.00K 392.00K 452.06K 446.19K 485.57K 95.38K 90.77K 162.23K 180.41K - - 4.85M 5.33M 4.19M 3.78M 4.31M - - - - - - - - -
Gross Profit -403.00K -392.00K -452.06K -446.19K -485.57K -95.38K -90.77K -162.23K -180.41K - - - -5.33M -4.19M -3.78M -4.31M - - 783.46K 699.76K 313.31K 208.87K - 310.00K 1.00
Operating Income -33.79M -28.57M -26.23M -25.46M -20.69M -16.66M -15.61M -15.29M -13.92M -18.82M -23.90M -36.69M -28.72M -20.04M -17.00M -18.07M -16.85M -15.50M -12.53M -12.63M -6.62M -6.75M -7.14M -4.65M -577.37K
Interest Income 1.33M 528.00K 98.61K 121.19K 179.28K 173.50K 130.10K 163.90K 197.86K 210.39K 371.49K 345.00K 416.25K 76.93K 30.83K 519.26K 1.21M 1.23M 783.46K 699.76K 313.31K 208.87K 655.21K 905.69K -
Pretax Income -27.66M -24.75M -26.25M -22.51M -33.12M -16.49M -15.48M -15.13M -13.72M -18.61M -23.53M -36.34M -29.00M -19.97M -16.97M -17.55M -15.64M -14.30M -12.78M -12.96M -8.51M -6.75M -6.48M -3.74M -
Net Income -27.75M -24.84M -26.30M -19.55M -45.55M -17.04M -15.62M -15.14M -13.72M -18.62M -23.53M -36.37M -29.04M -19.97M -17.00M -17.55M -15.64M -14.30M -12.78M -12.96M -8.54M -6.09M -6.17M -3.61M -574.46K
Selling & General & Admin 16.08M 11.49M 12.86M 12.07M 8.84M 7.08M 6.21M 5.36M 5.14M 5.00M 372.74K 730.75K 1.14M 3.25M 4.40M 64.04K 4.53M 4.03M 3.15M 5.47M 2.95M 2.10M 1.56M 1.06M 89.03K
Research & Development 17.71M 15.43M 12.92M 12.94M 11.13M 9.42M 9.39M 9.77M 8.60M 13.82M 18.51M 31.40M 23.39M 12.19M 12.15M 13.35M 11.32M 10.54M 9.31M 7.11M 3.31M 4.28M 5.12M 3.69M 486.66K
Other Expenses - - 13.31M 12.51M 9.56M 7.24M 6.21M 162.23K 180.41K 5.00M 5.02M 4.55M - 409.84K 425.40K 341.97K 5.53M 4.96M 4.00M 6.22M 3.62M 2.68M 2.02M 1.27M 90.71K
Operating Expenses 33.79M 26.92M 26.23M 25.46M 20.69M 16.66M 15.61M 15.29M 13.92M 18.82M 23.90M 36.69M 28.72M 15.51M 17.00M 13.76M 16.85M 15.50M 13.31M 13.33M 6.93M 6.96M 7.14M 4.96M 577.37K
Interest Expense - 528.00K - - - - - - - - - - - - - - - - - - - - - - -
Selling & Marketing Expenses - - -452.49K -445.69K - - - - - - - - - - - - - - - - - - - - -
Cost & Expenses 33.79M 26.92M 26.23M 25.46M 20.69M 16.66M 15.61M 15.29M 13.92M 18.82M 23.90M 36.69M 28.72M 19.70M 17.00M 18.07M 16.85M 15.50M 13.31M 13.33M 6.93M 6.96M 7.14M 4.96M 577.37K
Income Tax 97.00K 84.00K 49.43K -2.95M 12.43M 548.04K 141.50K 9.37K 3.15K 6.78K 5.41K 30.47K 40.00K 7.61K 23.04K - -1.20M -1.20M -1.52K 323.88K 33.55K -659.90K -310.57K -126.81K -2.91K
Shares Outstanding (Basic) 67.62M 58.03M 53.51M 40.34M 22.14M 16.02M 13.94M 12.62M 11.85M 9.25M 8.79M 8.01M 7.46M 6.58M 5.20M 4.35M 4.26M 3.82M 3.44M 3.01M 2.45M 2.23M 1.95M 1.73M 616.48K
Shares Outstanding (Diluted) 67.62M 58.03M 53.51M 40.34M 22.14M 16.02M 13.94M 12.62M 11.85M 9.25M 8.79M 8.01M 7.46M 6.58M 5.20M 4.35M 4.26M 3.82M 3.44M 3.01M 2.45M 2.23M 1.95M 1.83M 616.48K
EPS (Basic) -0.41 -0.43 -0.49 -0.48 -2.06 -1.06 -1.12 -1.2 -1.16 -2.01 -2.68 -4.54 -3.89 -3.04 -3.27 -4.03 -3.68 -3.74 -3.71 -4.31 -3.48 -2.74 -3.17 -2.09 -0.93
EPS (Diluted) -0.41 -0.43 -0.49 -0.48 -2.06 -1.06 -1.12 -1.2 -1.16 -2.01 -2.68 -4.54 -3.89 -3.04 -3.27 -4.03 -3.68 -3.74 -3.71 -4.31 -3.48 -2.74 -3.17 -1.98 -0.93
EBITDA -33.71M -26.83M -25.66M -25.37M -20.02M -17.18M -15.51M -15.13M -13.74M -18.66M -23.77M -36.58M -27.93M -19.29M -16.75M -17.66M -15.83M -14.53M -12.46M -12.58M -5.95M -6.18M -6.67M -4.44M -575.69K
Depreciation & Amortization 81.00K 392.00K 452.06K 446.19K 485.57K 95.38K 90.77K 162.23K 180.41K 163.50K 131.62K 109.28K 92.59K 63.16K 257.25K 410.25K 1.00M 926.68K 855.99K 751.75K 663.52K 574.24K 465.45K 205.20K 1.68K